New Guidance on Modifications to Antimicrobial Susceptibility Testing
The new document provides framework for drug developers on appropriate use and modification of reference AST methods during antimicrobial development.
Read MorePosted by Edisource Vendor | Aug 25, 2025 | Compliance |
The new document provides framework for drug developers on appropriate use and modification of reference AST methods during antimicrobial development.
Read MorePosted by Edisource Vendor | Aug 21, 2025 | Information Technology |
The cloud-based EHR platform now offers real-time lab ordering and results delivery, eliminating the need for separate portals or fax-based communication.
Read MorePosted by Edisource Vendor | Aug 21, 2025 | POC Rapid Assays |
The app integrates rapid diagnostic testing, artificial intelligence, and telehealth capabilities, while the company’s decentralized clinical trial platform aims to reduce study costs and improve data collection.
Read MorePosted by Edisource Vendor | Aug 19, 2025 | Molecular Diagnostic Analyzers |
Community Direct DX, Scienetix, and Advanta Genetics R&D combine with $30 million in funding to create a vertically integrated PCR testing platform.
Read MorePosted by Edisource Vendor | Aug 18, 2025 | Dementias & Alzheimer’s |
The surface-enhanced Raman spectroscopy platform can detect amyloid beta biomarkers at ultra-low concentrations in body fluids, potentially enabling earlier diagnosis and monitoring of disease progression.
Read More